Urovant Sciences
Description: Urovant Sciences develops novel urologic treatments, including vibegron for overactive bladder & URO-902, a gene therapy for OAB.
Country: Switzerland
Based in: Basel
Founded: 2017
Funding Stage: Series A/B
Tags: ['Biopharma', 'Biotechnology', 'Health Care', 'Medical']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
